BioAdvantage provides business analysis services to pharmaceutical companies wishing to expand their product portfolio.
We can identify strategic options for new products to add to an existing pharmaceutical product portfolio, to meet agreed criteria for business growth.
- Portfolio gap analysis
- Recommendations for prioritisation of pipeline projects based on agreed criteria.
- Global new product search, screening and commercial evaluation.
- Commercial due diligence of in-licensing and acquisition opportunities, including market research.
- Business cases for investment.
- Product launch plans.